MBX

MBX Biosciences, Inc.
54.16 +2.25% 2026-10-28

Last 90d 1 insider sale

52-week range
16.95 72.64
1-month-6.2%
3-month-18.5%
1-year+210.6%
vs 50-day-7.1%
vs 200-day+19.2%
Volatility79%
Beta1.05
$ vol/day$31M
ATH72.64
From ATH-25.4%
Next report2026-11-05
WhoEntryMove What they saidWhen
TRACKER - Insider Trades long 18.12 +201.0% Fhmls X, L.P. has been buying MBX. The buy: Fhmls X, L.P., a 10%+ owner, bought 666,666 shares of MBX on 26 September… Tue, 30 Sep 2025
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
3mo sell 1 $24,335 69.84
6mo sched 1 $2,685,515 42.62
6mo sell 2 $24,755 37.92
8mo buy 1 $525,585 30.20
1.0y buy 1 $272,800 14.79
1.0y buy 1 $265,000 13.75
1.1y buy 1 $11,999,988 17.55
1.6y buy 1 $45,312 6.38
1.7y buy 2 $4,041,511 10.89
1.7y buy 1 $534,500 11.35
2.1y buy 15 $136,000,000 21.90

Next report 2026-11-05 (Thursday, before open, in 7 days) · EPS estimate -0.84. It has finished the next session higher 62% of the time, average move 3.8%.

Day-after move, last 8 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-08-06 miss -0.59 -0.78 -33.2% -1.9% -0.5% -0.6%
2026-05-07 beat -0.58 -0.51 +12.2% -0.4% +8.1% +10.1%
2026-03-12 beat -0.60 -0.49 +17.9% -1.9% -3.4% -1.8%
2025-11-06 beat -0.68 -0.63 +7.0% -0.1% +9.7% +6.7%
2025-08-07 beat -0.76 -0.58 +24.0% +1.7% -4.6% +13.2%
2025-05-12 beat -0.77 -0.71 +7.9% +0.6% +0.3% +9.4%
2025-03-17 beat -0.59 -0.47 +19.9% +5.7% +1.7% -6.6%
2024-11-07 miss -2.72 -2.78 -2.3% -1.0% +2.1% -14.3%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
+0.1%
Next 1 month
+2.8%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 87
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.05%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.05 +2.8%
$31M/day volume 79% volatility +211% 1-year -25% from ATH
52-week range · 67% of the way up · -25% from the high
$16.95$72.64

Not investment advice.